Medication info
Januritine Tablet 25 mg (Sitagliptin Hydrochloride Hydrate)

Januritine Tablet 25 mg (Sitagliptin Hydrochloride Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›128.5mg / 1 tablet
Manufacturer / importer
Daewon Pharmaceutical Co., Ltd.
Appearance
Pink, round, double-convex, film-coated tablet
Packaging
30 tablets - 10 tablets/PPP[x3]
Approval status
Active

MFDS item code 202002248 · Approved 2020.03.31 · Insurance code 671807140

Summary

Main use
Improvement of blood glucose control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This drug is administered at 100 mg once daily, as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This drug may be taken regardless of meals. When this drug is administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Because dosage adjustment according to renal function is required, renal function should be assessed before treatment and periodically thereafter. No dosage adjustment is required for patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). No dosage adjustment is required for patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). For patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. For patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This drug may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
Daewon Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in type 2 diabetes mellitus

  • Difficulty in blood glucose control in type 2 diabetes patients
View approved original text

This medication is used in conjunction with dietary and exercise therapy to assist patients with type 2 diabetes in controlling their blood glucose levels. It can be used alone, but in cases where blood glucose control is difficult, it can be combined with other antidiabetic agents such as metformin. It is beneficial for those who have not previously received diabetes medication to improve blood glucose levels through either monotherapy or combination therapy. When monotherapy or combination therapy with sulfonylureas, metformin, thiazolidinediones, or insulin is insufficient, adding this medication can enhance blood glucose control. This supports optimal blood glucose control tailored to individual patients through various combinations. Therefore, this medication is useful for improving blood glucose control in patients with type 2 diabetes.

How to take

Adult dose

This drug is administered at 100 mg once daily, as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This drug may be taken regardless of meals. When this drug is administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Because dosage adjustment according to renal function is required, renal function should be assessed before treatment and periodically thereafter. No dosage adjustment is required for patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). No dosage adjustment is required for patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). For patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. For patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This drug may be administered regardless of the timing of dialysis.

Precautions

This medication may cause allergic reactions; therefore, individuals who have previously had an allergy to this medication or its components should not take it. If severe allergic symptoms such as a skin rash, difficulty breathing, or swelling of the face or neck occur during use, it should be discontinued immediately and a doctor must be consulted. There is a possibility of pancreatitis (inflammation of the pancreas) within three months after taking this medication. If symptoms such as abdominal pain, nausea, or vomiting appear, consult a doctor immediately. Patients with impaired renal function need dosage adjustments, so kidney function tests should be done and the medication should be taken under the doctor's guidance. This medication can cause hypoglycemia; therefore, when used with insulin or sulfonylurea agents, one must monitor for symptoms of hypoglycemia and may need to adjust the doses of other medications if necessary. Long-term use may result in side effects such as headache, upper respiratory infections, nasopharyngitis, joint pain, diarrhea, etc., so if symptoms are severe, consult a doctor. Elderly patients should have their renal function periodically checked before and during the use as it may decline. Pregnant or nursing women should avoid taking this medication as its safety has not been established, and it has not been confirmed for safety and efficacy in children under 18 years of age. In case of overdose, seek appropriate treatment immediately at a hospital, as some of the medication may be removed through dialysis. If any abnormal symptoms such as blisters or itching occur on the skin during the use of this medication, notify a doctor immediately, and consider stopping the medication if necessary. No significant interactions have been reported when used with other medications, but attention should be paid to the condition if digoxin is being taken.

Side effects

  • Anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hypoglycemia
  • upper respiratory tract infection
  • nasopharyngitis
  • headache
  • diarrhea
  • abdominal pain
Show 32 more
  • nausea
  • constipation
  • vomiting
  • rash
  • urticaria
  • cutaneous vasculitis
  • elevated liver enzymes
  • acute renal failure
  • severe and disabling arthralgia
  • bullous pemphigoid-like rash
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • dyspepsia
  • dizziness
  • increased ALT
  • increased AST
  • elevated blood triglycerides
  • gastritis
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction
  • pneumonia
  • diabetic complications
  • metabolic acidosis
  • falls
  • cardiac arrest

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air ingress, and it is best kept at room temperature between 1 degree and 30 degrees Celsius. Proper storage will maintain the medication's effectiveness for a longer time.

Appearance and packaging

Appearance

Pink, round, double-convex, film-coated tablet

Package unit

30 tablets - 10 tablets/PPP[x3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.